Cart
sales@molnova.com
Continentalic acid
CAS No. 19889-23-7
Continentalic acid( —— )
Catalog No. M23897 CAS No. 19889-23-7
Continentalic acid from Aralia continentalis has minimum inhibitory concentrations (MICs) of approximately 8-16 μg/mL against S. aureus.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 85 | In Stock |
|
| 10MG | 136 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameContinentalic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionContinentalic acid from Aralia continentalis has minimum inhibitory concentrations (MICs) of approximately 8-16 μg/mL against S. aureus.
-
DescriptionContinentalic acid from Aralia continentalis has minimum inhibitory concentrations (MICs) of approximately 8-16 μg/mL against S. aureus, including the Methicillin susceptible Staphylococcus aureus (MSSA) and Methicillin-resistant Staphylococcus aureus (MRSA) standard strains.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX|NOS|PGE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number19889-23-7
-
Formula Weight302.5
-
Molecular FormulaC20H30O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (330.63 mM)
-
SMILESC[C@](CCC1)([C@@H](CC2)[C@@]1(C)C(O)=O)[C@@H](CC1)C2=C[C@]1(C)C=C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.In vitro Cytotoxicity of Methanol Extract from Aerial Parts of Aralia cachemirica and Purified Continentalic Acid.Indian J Pharm Sci. 2015 Nov-Dec;77(6):792-5.
molnova catalog
related products
-
Acetylsalicylic acid
Aspirin (Acetylsalicylic acid) is a potent and selective inhibitor of cyclooxygenase (COX) with a broad range of pharmacological activities including anti-inflammation and pain relief.
-
Valdecoxib
Valdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about possible increased risk of heart attack and stroke.
-
Bromfenac Sodium b
Bromfenac Sodium is a nonsteroidal anti-inflammatory drug (NSAID) which has anti-inflammatory activity and may block prostaglandin synthesis by inhibiting cyclooxygenase 1 and 2.
